Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-02-03 @ 3:36 PM
Study NCT ID:
NCT06799520
Status:
RECRUITING
Last Update Posted:
2025-09-17
First Post:
2025-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization: